Citadel Advisors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Citadel Advisors’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,251	Closed	-$278K	–	9054
2015 Q4	$278K	Buy	+10,251	New	+$264K	﹤0.01%	5332
2015 Q3	–	Sell	-367,674	Closed	-$10.5M	–	9550
2015 Q2	$10.5M	Buy	367,674 +251,423	+216%	+$7.33M	0.01%	1446
2015 Q1	$3.18M	Sell	116,251 -5,066	-4%	-$139K	﹤0.01%	2520
2014 Q4	$3.2M	Buy	121,317 +78,979	+187%	+$2.31M	﹤0.01%	2410
2014 Q3	$1.28M	Buy	+42,338	New	+$1.31M	﹤0.01%	3405
2014 Q2	–	Sell	-23,009	Closed	-$745K	–	8603
2014 Q1	$745K	Buy	+23,009	New	+$805K	﹤0.01%	3809
2013 Q3	–	Sell	-11,346	Closed	-$425K	–	7015
2013 Q2	$425K	Buy	+11,346	New	+$448K	﹤0.01%	3978

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Citadel Advisors's MR Position: Q1 2016 in Review

Citadel Advisors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 10,251 shares — an estimated $278K sold.

Citadel Advisors first reported a position in MR in Q2 2013 and held it in 7 quarters. The position peaked at $10.5M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Citadel Advisors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Citadel Advisors sold 10,251 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $278K.
Citadel Advisors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 7 quarters.
Citadel Advisors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $10.5M in Q2 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Citadel Advisors's 13F filing for Q1 2016, filed 13 May 2016.